Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17,004 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of ABCG2 dysfunction as a major factor contributing to gout.
Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Takada Y, Okada C, Sakurai Y, Hosoya T, Kanai Y, Suzuki H, Shinomiya N. Matsuo H, et al. Among authors: nakamura t. Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1098-104. doi: 10.1080/15257770.2011.627902. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132963
An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. Kamatani N, et al. Among authors: nakamura t. J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S13-8. doi: 10.1097/RHU.0b013e31821d36cc. J Clin Rheumatol. 2011. PMID: 21654265 Clinical Trial.
An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. Kamatani N, et al. Among authors: nakamura t. J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S44-9. doi: 10.1097/RHU.0b013e31821d352f. J Clin Rheumatol. 2011. PMID: 21654269 Clinical Trial.
Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. Kamatani N, et al. Among authors: nakamura t. J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S35-43. doi: 10.1097/RHU.0b013e31821d351d. J Clin Rheumatol. 2011. PMID: 21654268 Clinical Trial.
Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y. Kamatani N, et al. Among authors: nakamura t. J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S19-26. doi: 10.1097/RHU.0b013e31821d36de. J Clin Rheumatol. 2011. PMID: 21654266 Clinical Trial.
Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus.
Koizumi K, Okamoto H, Iikuni N, Nakamura T, Kawamoto M, Momohara S, Ichikawa N, Furuya T, Kotake S, Taniguchi A, Yamanaka H, Kamatani N. Koizumi K, et al. Among authors: nakamura t. Ann Rheum Dis. 2005 Jun;64(6):947-50. doi: 10.1136/ard.2004.025767. Ann Rheum Dis. 2005. PMID: 15897313 Free PMC article.
Reduced histone H3K4 trimethylation in oral mucosa of patients with DYT-KMT2B.
Sugeno N, Kumada S, Kashii H, Ikezawa J, Kawarai T, Nakamura T, Miyata A, Ishiyama S, Sato K, Yoshida S, Sekiguchi H, Hamanaka K, Miyatake S, Miyake N, Matsumoto N, Akagawa H, Kosaki K, Yoshihashi H, Hasegawa T, Aoki M. Sugeno N, et al. Among authors: nakamura t. Parkinsonism Relat Disord. 2024 May 27;124:107018. doi: 10.1016/j.parkreldis.2024.107018. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 38810319
Scaphoid Fracture/Nonunion.
Nakamura T. Nakamura T. J Wrist Surg. 2024 May 27;13(3):193. doi: 10.1055/s-0044-1786870. eCollection 2024 Jun. J Wrist Surg. 2024. PMID: 38808182 No abstract available.
17,004 results
You have reached the last available page of results. Please see the User Guide for more information.